Joel Isaacson & Co., LLC Evogene Ltd. Transaction History

Joel Isaacson & Co., LLC

  • $1.82 Billion
  • Q1 2024

A detailed history of Joel Isaacson & Co., LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Joel Isaacson & Co., LLC holds 30,300 shares of EVGN stock, worth $19,695. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,300
Previous 30,300 -0.0%
Holding current value
$19,695
Previous $25,000 12.0%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 26, 2023
BUY
$0.56 - $1.2 $168 - $360
300 Added 1.0%
30,300 $32,000
Q4 2022

Jan 27, 2023
BUY
$0.61 - $0.78 $18,300 - $23,400
30,000 New
30,000 $0

Others Institutions Holding EVGN

# of Institutions
32
Shares Held
4.08M
Call Options Held
23K
Put Options Held
0
View Full List

About Evogene Ltd.

EVGN Quotes by TradingView
  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $26.8M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Joel Isaacson & Co., LLC Portfolio

Follow Joel Isaacson & Co., LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Joel Isaacson & Co., LLC, based on Form 13F filings with the SEC.

News

Stay updated on Joel Isaacson & Co., LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email